UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Model-based inference of neutralizing antibody avidities against influenza virus

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010243-e1010243

2022

Volltextzugriff (PDF)

Dissociations of oral foci of infections with infectious complications and survival after haematopoietic stem cell transplantation

PloS one, 2019-12, Vol.14 (12), p.e0225099-e0225099

2019

Volltextzugriff (PDF)

Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation

Chest, 2018-07, Vol.154 (1), p.157-168

2018

Volltextzugriff (PDF)

Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study

Annals of hematology, 2019-06, Vol.98 (6), p.1485-1493

2019

Volltextzugriff (PDF)

New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

In vivo (Athens), 2020-11, Vol.34 (6), p.3545-3549

2020

Volltextzugriff (PDF)

Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia

The Lancet (British edition), 2024-02, Vol.403 (10425), p.469-470

2024

Volltextzugriff (PDF)

True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report

Current oncology (Toronto), 2024-04, Vol.31 (4), p.2067-2075

2024

Volltextzugriff (PDF)

Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study

Bone marrow transplantation (Basingstoke), 2022-04, Vol.57 (4), p.613-619

2022

Volltextzugriff (PDF)

Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs

Swiss medical weekly, 2024-05, Vol.154, p.3754

2024

Volltextzugriff (PDF)

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data

Swiss medical weekly, 2024-10, Vol.154 (10), p.3704

2024

Volltextzugriff (PDF)

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience

Leukemia & lymphoma, 2020-09, Vol.61 (11), p.2568-2583

2020

Volltextzugriff (PDF)

Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate

Annals of hematology, 2017-04, Vol.96 (4), p.681-682

2017

Volltextzugriff (PDF)

Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia

Annals of hematology, 2024-11, Vol.103 (11), p.4831-4833

2024

Volltextzugriff (PDF)

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes

Frontiers in oncology, 2023-08, Vol.13, p.1205387-1205387

2023

Volltextzugriff (PDF)

Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre‐HSCT

European journal of haematology, 2019-04, Vol.102 (4), p.351-356

2019

Volltextzugriff (PDF)

Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation

Swiss medical weekly, 2019-11, Vol.149, p.w20150

2019

Volltextzugriff (PDF)

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

Blood, 2007-11, Vol.110 (9), p.3463-3471

2007

Volltextzugriff (PDF)

Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient’s perspective?

Supportive care in cancer, 2021-06, Vol.29 (6), p.3129-3135

2021

Volltextzugriff (PDF)

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.858-866

2019

Volltextzugriff (PDF)

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2022-02, Vol.57 (2), p.224-231

2022

Volltextzugriff (PDF)

Hypothyroidism Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Leukemia research, 2017-07, Vol.58, p.43-47

2017

Volltextzugriff (PDF)

Common oral diseases, hyposalivation and survival post‐HSCT, a longitudinal study

European journal of haematology, 2019-10, Vol.103 (4), p.300-306

2019

Volltextzugriff (PDF)

Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine

Frontiers in cardiovascular medicine, 2023-04, Vol.10, p.1135848

2023

Volltextzugriff (PDF)

ROCKin' cGVHD treatment: has the time come?

Blood, 2021-12, Vol.138 (22), p.2161-2163

Halter, Jörg P.

2021

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(192)
Deutsch
(21)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(158)
Life Sciences & Biomedicine
(153)
Humans
(122)
Adult
(68)
Female
(68)
Male
(68)
Hematology
(66)
Middle Aged
(63)
Transplantation
(60)
Aged
(44)
Immunology
(43)
Oncology
(33)
Hematopoietic Stem Cell Transplantation
(28)
Stem Cells
(28)
Infectious Diseases
(27)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(26)
Medicine
(26)
Patients
(26)
Risk Factors
(26)
Stem Cell Transplantation
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Model-based inference of neutralizing antibody avidities against influenza virus

Dissociations of oral foci of infections with infectious complications and survival after haematopoietic stem cell transplantation

Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation

Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study

New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia

True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report

Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study

Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience

Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate

Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes

Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre‐HSCT

Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient’s perspective?

Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation

Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021

Hypothyroidism Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Common oral diseases, hyposalivation and survival post‐HSCT, a longitudinal study

Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine

ROCKin' cGVHD treatment: has the time come?

Suchergebnisse filtern